Stephen J. Haleen - Concepedia

Author

Stephen J. Haleen

Warde Medical Laboratory

Also Known As

S J Haleen, S. Haleen, S. J. HALEEN, S. J. Haleen, S.J. Haleen, Stephen Haleen, Stephen J Haleen, Stephen J. Haleen

Publications

Citations

H-Index

Concepts

All Affiliations

Warde Medical Laboratory Warner University Pfizer (United States)University of Alberta Time Warner (United States)

About

Stephen J. Haleen is an author at Warde Medical Laboratory specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	666
2	Biochemistry	5	5	205
3	Natural Sciences	4	4	180
4	Public Health	2	2	44
5	Health Sciences	1	1	62

Stephen J. Haleen

Publications

990

Citations

H-Index

Page 1

	Year	Citations
Design of a Potent Combined Pseudopeptide Endothelin-A/Endothelin-B Receptor Antagonist, Ac-<scp>d</scp>Bhg<sup>16</sup>-Leu-Asp-Ile-[NMe]Ile-Trp<sup>21</sup>(PD 156252): Examination of Its Pharmacokinetic and Spectral Properties Wayne L. Cody, John X. He, Michael D. Reily, Journal of Medicinal Chemistry Pd 156252Peptide ScienceExperimental PharmacologyGastrointestinal Peptide HormoneMolecular Pharmacology	1997	96
PD 116,948, a highly selective A1 adenosine receptor antagonist Stephen J. Haleen, R. Steffen, Harriet W. Hamilton Life Sciences Pd 116,948Molecular PharmacologyG Protein-coupled ReceptorMedicineFunctional Selectivity	1987	88
ETA and ETB Receptors Coexist on Rabbit Pulmonary Artery Vascular Smooth Muscle Mediating Contraction D. M. LaDouceur, Mary Flynn, Joan A. Keiser, Biochemical and Biophysical Research Communications Pulmonary Arterial HypertensionMolecular PhysiologyPulmonary CirculationCell SignalingMedicine	1993	87
Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist. Elwood E. Reynolds, Joan A. Keiser, Stephen J. Haleen, Journal of Pharmacology and Experimental Therapeutics	1995	71
In Vitro and In Vivo Studies with a Series of Hexapeptide Endothelin Antagonists Annette M. Doherty, Wayne L. Cody, J. X. He, Journal of Cardiovascular Pharmacology	1993	64
Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates. Stephen J. Haleen, Ronald E. Weishaar, R W Overhiser, Circulation Research HypertensionHeart FailureGs HamstersCm HamstersCardiomyopathic Hamster	1991	62
Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application Harriet W. Hamilton, Daniel F. Ortwine, Donald F. Worth, Journal of Medicinal Chemistry	1985	60
Structure−Activity Relationships in a Series of Orally Active γ-Hydroxy Butenolide Endothelin Antagonists William C. Patt, Jeremy J. Edmunds, Joseph T. Repine, Journal of Medicinal Chemistry Selective Antagonist Pd155080Pharmaceutical ScienceChemical BiologyExperimental PharmacologyMolecular Pharmacology	1997	46
Novel Selective Quinazoline Inhibitors of Endothelin Converting Enzyme-1 Kyunghye Ahn, Andre M. Sisneros, Sarah B. Herman, Biochemical and Biophysical Research Communications Medicinal ChemistryEndothelin Converting Enzyme-1MedicinePharmacological AgentPharmacotherapy	1998	45
Correlation of adenosine receptor affinities and cardiovascular activity Harriet W. Hamilton, Marianne Taylor, R. Steffen, Life Sciences Adenosine Receptor AffinitiesCardiovascular DiseaseMedicinePhysiologyVascular Biology	1987	43

Page 1